Completed PHASE2 INTERVENTIONAL NCT00001956

Influence of Genetics in Pain Sensitivity

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)

Interventions Blood draw Oral surgery Tissue biopsy

Updated 5 times since 2017 Last updated: Jun 29, 2006 Started: Jan 31, 2000 Completion: Feb 28, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Healthy and Hyperalgesia and is currently completed. National Institute of Dental and Craniofacial Research (NIDCR) leads this study, which shows 5 recorded versions since 2000 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Dental and Craniofacial Research (NIDCR)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States